Lee's Pharma In-Licenses Ear Infection Treatment from Salvat for China
January 12, 2016 at 04:07 AM EST
Lee's Pharma, a Hong Kong company, acquired China rights to a treatment for ear infections from Laboratorios Salvat of Barcelona. Duoxal ® ear drops, a patented combination solution of Ciprofloxacin and Fluocinolone Acetonide, treats acute otitis media in patients with tympanostomy tubes and acute otitis externa (swimmer's ear) in adults and children older than 6 months of age. Salvat will supply Lee's with Duoxal. More details.... Stock Symbol: (HK: 0950) Share this with colleagues: // //